HCV inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 27, 2009
Grant Date -
Mar 8, 2007
app pub date -
Jun 28, 2006
filing date -
Jun 30, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention is directed to compounds that are antiviral agents. Specifically the compounds of the present invention inhibit replication of HCV and are therefore useful in treating hepatitis C infections. The present invention is also directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully